STADA Gemfibrozilo 600 mg

STADA Gemfibrozilo is a generic pharmaceutical product used to lower triglyceride levels and improve cholesterol profiles. The STADA brand (an acronym for Standardpräparate Deutscher Apotheker) has its roots in Germany, where it was founded in 1895 as a cooperative for pharmacists to produce standardized medicines.

Today, STADA Arzneimittel AG is a major global player in the generic and consumer healthcare sector. While the brand originated in Germany, it is currently owned by the private equity firms Bain Capital and Cinven, which acquired the company in 2017. Manufacturing for its vast portfolio of generic drugs occurs across multiple global sites, including significant facilities in Germany, Serbia, and Russia, as well as utilizing contract manufacturing organizations (CMOs) worldwide. In Spain, the product is managed by the local subsidiary Laboratorio STADA, S.L.